Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2020 October;68(5) > Minerva Cardioangiologica 2020 October;68(5):386-92

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  PCI HOT TOPICS 

Minerva Cardioangiologica 2020 October;68(5):386-92

DOI: 10.23736/S0026-4725.20.05312-8

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Alessandra SCATTEIA 1, Anna BARITUSSIO 2, Chiara BUCCIARELLI-DUCCI 3

1 Division of Cardiology, Villa dei Fiori Hospital, Acerra, Naples, Italy; 2 Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy; 3 Bristol Heart Institute, NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, UK



Coronary artery disease (CAD) is the leading cause of death worldwide and improving the prognosis and survival of patients with ischemic heart disease remains a priority of cardiovascular specialists. This article will review the principles of myocardial viability, present the noninvasive imaging tests available to clinicians, as well as critically appraise the latest literature on myocardial viability, coronary revascularization and outcome with a final outlook at studies in the pipelines and future evidence in myocardial viability that will be soon available.


KEY WORDS: Acute coronary syndrome; Coronary artery disease; Myocardium

top of page